The Supreme Cannabis Company Inc. (TSX.V: FIRE) (O
Post# of 316
(Total Views: 164)
Posted On: 01/09/2019 4:07:02 PM
The Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF) (FRA: 53S1) Set to Have All 25 7ACRES Flowering Rooms Completed by March 2019
- Supreme Cannabis recently provided a 7ACRES construction update, announcing that 19 flowering rooms have been completed and the remaining six are expected to be ready by March 2019
- The modular design of the facility enables independent adjustment of crop cultivation conditions, resulting in higher quality and better yield
- According to Supreme Cannabis, 7ACRES’ production capacity will reach 50,000 kilograms by mid-2019
The Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF) (FRA: 53S1) recently announced that it has completed 19 of the 7ACRES flowering rooms and is on target to complete all 25 by March 2019. Once construction is finalized, 7ACRES will have a greenhouse footprint of nearly 300,000 square feet (http://nnw.fm/UAie1).
Under the updated timeline provided by Supreme Cannabis, three additional flowering rooms will become operational in January, and, following completion of all 25 flowering rooms in March, the primary office and administrative areas will be finalized by the end of the first half of 2019.
The estimated annual output of Supreme Cannabis Company’s flagship brand and wholly owned subsidiary 7ACRES is on pace to reach 50,000 kilograms by mid-2019. The addition of the greenhouse flowering rooms will increase the total size of the facility to 440,000 square feet.
According to the Supreme Cannabis management team, 7ACRES is a unique facility for Canada, with an unparalleled ability to produce high-quality cannabis on a commercial scale and each flowering room utilizing sophisticated HPS lighting technology to ensure the quality of indoor lighting. The additional lights are supplementary to the sunlight entering the flowering rooms and are needed to improve terpene and cannabinoid production.
7ACRES is characterized by the modular design of each of the flowering rooms. As a result, the environmental conditions in each room can be adjusted independently of the other facility modules. The risk of losses is reduced exponentially through tailored cultivation conditions that are precisely chosen for each crop.
Any expansion of the facility is the subject of Health Canada regulatory approval. Upon completion of the flowering rooms, Supreme Cannabis plans to streamline the Health Canada review by submitting multiple rooms for simultaneous review.
“7ACRES sets the international standard for cannabis cultivation and allows us to grow craft-quality cannabis at scale,” Supreme Cannabis president and Founder John Fowler said in a news release. “We believe consumer behaviour has validated our thesis that people prefer higher-quality flower and are willing to pay more for it, and as the market expands for derivative products such as vape pens and edibles we expect consumers will prefer products extracted from the highest quality inputs.”
7ACRES is a cultivation facility that ranks among the first 40 federally licensed cannabis producers in Canada. Through a focus on scaled cannabis production, 7ACRES will enjoy a high level of flexibility as the Canadian market continues to grow.
The quality of 7ACRES’ production is one of its primary strengths, as Supreme Cannabis has noted. This high level of quality was officially recognized when 7ACRES received a ‘Brand of the Year’ award in 2018 at the Canadian Cannabis Awards (http://nnw.fm/YlRi3).
Supreme Cannabis is a Canadian publicly-traded company committed to providing premium brands and products. Its portfolio includes the wholly owned 7ACRES subsidiary, an equity investment and a long-term global distribution partnership with Lesotho-based Medigrow.
For more information, visit the company’s website at www.Supreme.ca
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
- Supreme Cannabis recently provided a 7ACRES construction update, announcing that 19 flowering rooms have been completed and the remaining six are expected to be ready by March 2019
- The modular design of the facility enables independent adjustment of crop cultivation conditions, resulting in higher quality and better yield
- According to Supreme Cannabis, 7ACRES’ production capacity will reach 50,000 kilograms by mid-2019
The Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF) (FRA: 53S1) recently announced that it has completed 19 of the 7ACRES flowering rooms and is on target to complete all 25 by March 2019. Once construction is finalized, 7ACRES will have a greenhouse footprint of nearly 300,000 square feet (http://nnw.fm/UAie1).
Under the updated timeline provided by Supreme Cannabis, three additional flowering rooms will become operational in January, and, following completion of all 25 flowering rooms in March, the primary office and administrative areas will be finalized by the end of the first half of 2019.
The estimated annual output of Supreme Cannabis Company’s flagship brand and wholly owned subsidiary 7ACRES is on pace to reach 50,000 kilograms by mid-2019. The addition of the greenhouse flowering rooms will increase the total size of the facility to 440,000 square feet.
According to the Supreme Cannabis management team, 7ACRES is a unique facility for Canada, with an unparalleled ability to produce high-quality cannabis on a commercial scale and each flowering room utilizing sophisticated HPS lighting technology to ensure the quality of indoor lighting. The additional lights are supplementary to the sunlight entering the flowering rooms and are needed to improve terpene and cannabinoid production.
7ACRES is characterized by the modular design of each of the flowering rooms. As a result, the environmental conditions in each room can be adjusted independently of the other facility modules. The risk of losses is reduced exponentially through tailored cultivation conditions that are precisely chosen for each crop.
Any expansion of the facility is the subject of Health Canada regulatory approval. Upon completion of the flowering rooms, Supreme Cannabis plans to streamline the Health Canada review by submitting multiple rooms for simultaneous review.
“7ACRES sets the international standard for cannabis cultivation and allows us to grow craft-quality cannabis at scale,” Supreme Cannabis president and Founder John Fowler said in a news release. “We believe consumer behaviour has validated our thesis that people prefer higher-quality flower and are willing to pay more for it, and as the market expands for derivative products such as vape pens and edibles we expect consumers will prefer products extracted from the highest quality inputs.”
7ACRES is a cultivation facility that ranks among the first 40 federally licensed cannabis producers in Canada. Through a focus on scaled cannabis production, 7ACRES will enjoy a high level of flexibility as the Canadian market continues to grow.
The quality of 7ACRES’ production is one of its primary strengths, as Supreme Cannabis has noted. This high level of quality was officially recognized when 7ACRES received a ‘Brand of the Year’ award in 2018 at the Canadian Cannabis Awards (http://nnw.fm/YlRi3).
Supreme Cannabis is a Canadian publicly-traded company committed to providing premium brands and products. Its portfolio includes the wholly owned 7ACRES subsidiary, an equity investment and a long-term global distribution partnership with Lesotho-based Medigrow.
For more information, visit the company’s website at www.Supreme.ca
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)Supreme Pharmaceuticals (SPRWF) Stock Research Links
Scroll down for more posts ▼